The future of targeted peptidomics
Targeted MS is becoming increasingly important for sensitive and specific quantitative detection of proteins and respective PTMs. In this article, Ceglarek et al. [Proteomics Clin. Appl. 2013, 7, 794-801] present an LC-MS-based method for simultaneous quantitation of seven apolipoproteins in serum s...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 November 2013
|
| In: |
Proteomics. Clinical applications
Year: 2013, Volume: 7, Issue: 11/12, Pages: 721-722 |
| ISSN: | 1862-8354 |
| DOI: | https://doi.org/10.1002/prca.201300116 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1002/prca.201300116 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201300116 
|
| Author Notes: | Peter Findeisen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1751391973 | ||
| 003 | DE-627 | ||
| 005 | 20230427005947.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210315s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/prca.201300116 |2 doi | |
| 035 | |a (DE-627)1751391973 | ||
| 035 | |a (DE-599)KXP1751391973 | ||
| 035 | |a (OCoLC)1341398346 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Findeisen, Peter |d 1965- |e VerfasserIn |0 (DE-588)124459943 |0 (DE-627)363363327 |0 (DE-576)294182098 |4 aut | |
| 245 | 1 | 4 | |a The future of targeted peptidomics |c Peter Findeisen |
| 264 | 1 | |c 12 November 2013 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.03.2021 | ||
| 520 | |a Targeted MS is becoming increasingly important for sensitive and specific quantitative detection of proteins and respective PTMs. In this article, Ceglarek et al. [Proteomics Clin. Appl. 2013, 7, 794-801] present an LC-MS-based method for simultaneous quantitation of seven apolipoproteins in serum specimens. The assay fulfills many necessities of routine diagnostic applications, namely, low cost, high throughput, and good reproducibility. We anticipate that validation of new biomarkers will speed up with this technology and the palette of laboratory-based diagnostic tools will hopefully be augmented significantly in the near future. | ||
| 650 | 4 | |a MRM | |
| 650 | 4 | |a MS | |
| 650 | 4 | |a Protein quantitation | |
| 650 | 4 | |a Targeted peptidomics | |
| 773 | 0 | 8 | |i Enthalten in |t Proteomics. Clinical applications |d Weinheim : Wiley VCH, 2007 |g 7(2013), 11/12, Seite 721-722 |h Online-Ressource |w (DE-627)530281872 |w (DE-600)2317130-3 |w (DE-576)277494516 |x 1862-8354 |7 nnas |a The future of targeted peptidomics |
| 773 | 1 | 8 | |g volume:7 |g year:2013 |g number:11/12 |g pages:721-722 |g extent:2 |a The future of targeted peptidomics |
| 856 | 4 | 0 | |u https://doi.org/https://doi.org/10.1002/prca.201300116 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201300116 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210315 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 124459943 |a Findeisen, Peter |m 124459943:Findeisen, Peter |d 60000 |d 63300 |e 60000PF124459943 |e 63300PF124459943 |k 0/60000/ |k 1/60000/63300/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1751391973 |e 388845347X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"2 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1862-8354"],"zdb":["2317130-3"],"eki":["530281872"],"doi":["10.1002/(ISSN)1862-8354"]},"origin":[{"dateIssuedDisp":"2007-","publisher":"Wiley VCH","dateIssuedKey":"2007","publisherPlace":"Weinheim"}],"recId":"530281872","language":["eng"],"note":["Fortsetzung der Druckausgabe","Gesehen am 5. November 2022"],"disp":"The future of targeted peptidomicsProteomics. Clinical applications","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"2","volume":"7","text":"7(2013), 11/12, Seite 721-722","issue":"11/12","pages":"721-722","year":"2013"},"titleAlt":[{"title":"Proteomics / Clinical applications"},{"title":"Proteomics clinical applications"}],"pubHistory":["1.2007 -"],"title":[{"title_sort":"Proteomics","title":"Proteomics","partname":"Clinical applications"}]}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"12 November 2013"}],"id":{"eki":["1751391973"],"doi":["10.1002/prca.201300116"]},"name":{"displayForm":["Peter Findeisen"]},"note":["Gesehen am 15.03.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1751391973","language":["eng"],"title":[{"title_sort":"future of targeted peptidomics","title":"The future of targeted peptidomics"}],"person":[{"given":"Peter","family":"Findeisen","role":"aut","roleDisplay":"VerfasserIn","display":"Findeisen, Peter"}]} | ||
| SRT | |a FINDEISENPFUTUREOFTA1220 | ||